National and Kapodistrian University of Athens
Η επίδραση της υπολιπιδαιμικής αγωγής - είτε με αναστολείς της σύνθεσης της χοληστερόλης είτε με αναστολείς της απορρόφησης της χοληστερόλης - στους δείκτες φλεγμονής και θρομβωτικούς και ιστικούς παράγοντες σε ασθενείς με δυσλιπιδαιμία
Abstract
dc:descriptionIntroduction: Statins have favourable effect on the lipid profile, decrease the total mortality and they also are reported as presenting many pleiotropic effects. The aim of this study was to determine and compare the pleiotropic effects of simvastatin (S) and ezetimibe (E) in dyslipidemic patients (pts). Materials and methods: Forty-four pts (20 postmenopausal women) with low-density lipoprotein cholesterol (LDL-C) > 130 mg/dl or LDL-C >100 mg/dl in pts with coronary artery disease or its equivalent, were treated with S (n=21) 10 mg daily or E (n=23) 10 mg daily. Blood sample were drawn before and three months after treatment. In both samples we measured the levels of total cholesterol, triglycerides, high-density cholesterol (HDL-C), LDL-C, apolipoprotein (apo) A, apo B, lipoprotein (a) [Lp(a)], homocysteine, tissue factor (TF), von Willebrand (vW) and C-reactive protein (CRP). The baseline lipid profile and the haematological parameters were similar in both groups. Results: S and E decreased total cholesterol (262 mg/dl to 189 mg/dl, p<0.001 and 268 mg/dl to 220 mg/dl, p=0.001, respectively), LDL-C (177 mg/dl to 114 mg/ dl, p<0.001 and 196 mg/dl to 146 mg/dl, p<0.001 respectively) and CRP levels (1.145 mg/dl to 0.3 mg/dl mg/dl, p=0.001 and 2.8 mg/dl to 0.8 mg/dl, p=0.005, respectively). Also, S reduced apoB (125 mg/dl to 93 mg/dl, p<0.001). Neither drug had influence on the levels of Lp(a), TF, vW and homocysteine. Conclusions: Both drugs improved the lipid profile and CRP levels. However, no influence on TF and vW was found. Our results do not suggest a pleiotropic effect of statins on inflammation beyond total cholesterol and LDL-C lowering.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kostakou, Peggy
- Κωστάκου, Παναγιώτα
Subjects
dc:subject × 19- Υπολιπιδαιμική αγωγή
- Σιμβαστατίνη
- Φλεγμονές, Δείκτες
- Θρομβωτικοί παράγοντες
- Ιστικοί παράγοντες
- Δυσλιπιδαιμίες
- Λιπίδια
- Simvastatin
- Ezetimibe
- Von willebrand factor
- Tissue factor
- C reactive protein (CRP)
- Dyslipidemias
- Hypolipidemic treatment
- Cholesterol
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18920